Metropolitan Life Insurance CO Exelixis, Inc. Transaction History

Metropolitan Life Insurance CO

$252 Million
Q4 2024

47 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$17.03 - $22.67 $1.17 Million - $1.56 Million	-68,816 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$15.84 - $21.88 $1.09 Million - $1.51 Million	68,816 New	68,816 $1.26 Million
Q4 2021 Mar 30, 2023	SELL	$15.84 - $21.88 $3,247 - $4,485	-205 Reduced 0.3%	68,816 $1.26 Million
Q4 2021 Feb 15, 2022	SELL	$15.84 - $21.88 $3,247 - $4,485	-205 Reduced 0.3%	68,816 $1.26 Million
Q3 2021 Jun 21, 2023	BUY	$16.3 - $21.14 $1.14 Million - $1.48 Million	69,907 New	69,907 $1.48 Million
Q3 2021 Mar 30, 2023	SELL	$16.3 - $21.14 $48,639 - $63,081	-2,984 Reduced 4.14%	69,021 $1.46 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $21.14 $48,639 - $63,081	-2,984 Reduced 4.14%	69,021 $1.46 Million
Q2 2021 Jun 21, 2023	BUY	$17.95 - $25.56 $1.29 Million - $1.84 Million	72,005 New	72,005 $1.31 Million
Q2 2021 Mar 30, 2023	BUY	$17.95 - $25.56 $201,273 - $286,604	11,213 Added 18.44%	72,005 $1.31 Million
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $1.29 Million - $1.84 Million	71,944 Added 117940.98%	72,005 $1.31 Million
Q1 2021 Jun 26, 2023	BUY	$20.53 - $25.22 $1.33 Million - $1.63 Million	64,757 New	64,757 $1.46 Billion
Q1 2021 Mar 30, 2023	SELL	$20.53 - $25.22 $22,316 - $27,414	-1,087 Reduced 1.76%	60,792 $1.37 Million
Q1 2021 May 14, 2021	SELL	$20.53 - $25.22 $1.27 Million - $1.56 Million	-61,818 Reduced 99.9%	61 $1.37 Million
Q4 2020 Jun 22, 2023	BUY	$18.39 - $24.8 $1.14 Million - $1.53 Million	61,879 New	61,879 $1.24 Million
Q4 2020 Mar 30, 2023	SELL	$18.39 - $24.8 $22,656 - $30,553	-1,232 Reduced 1.95%	61,879 $1.24 Million
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $22,656 - $30,553	-1,232 Reduced 1.95%	61,879 $1.24 Million
Q3 2020 Jun 26, 2023	BUY	$20.67 - $26.94 $1.3 Million - $1.7 Million	63,111 New	63,111 $1.54 Million
Q3 2020 Mar 30, 2023	SELL	$20.67 - $26.94 $57,876 - $75,432	-2,800 Reduced 4.25%	63,111 $1.54 Million
Q3 2020 Nov 13, 2020	SELL	$20.67 - $26.94 $57,876 - $75,432	-2,800 Reduced 4.25%	63,111 $1.54 Million
Q2 2020 Jun 26, 2023	BUY	$16.46 - $27.42 $1.08 Million - $1.81 Million	65,911 New	65,911 $1.56 Million
Q2 2020 Mar 30, 2023	SELL	$16.46 - $27.42 $337,018 - $561,424	-20,475 Reduced 23.7%	65,911 $1.56 Million
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $337,018 - $561,424	-20,475 Reduced 23.7%	65,911 $1.57 Million
Q1 2020 Jul 12, 2023	BUY	$14.46 - $21.8 $1.25 Million - $1.88 Million	86,386 New	86,386 $1.49 Million
Q1 2020 Mar 30, 2023	SELL	$14.46 - $21.8 $67,398 - $101,609	-4,661 Reduced 5.12%	86,386 $1.49 Million
Q1 2020 May 15, 2020	SELL	$14.46 - $21.8 $67,398 - $101,609	-4,661 Reduced 5.12%	86,386 $1.49 Million
Q4 2019 Jul 12, 2023	BUY	$15.15 - $18.89 $1.38 Million - $1.72 Million	91,047 New	91,047 $1.6 Million
Q4 2019 Mar 30, 2023	BUY	$15.15 - $18.89 $8,817 - $10,993	582 Added 0.64%	91,047 $1.6 Million
Q4 2019 Feb 14, 2020	BUY	$15.15 - $18.89 $8,817 - $10,993	582 Added 0.64%	91,047 $1.6 Million
Q3 2019 Jul 12, 2023	BUY	$17.68 - $22.65 $1.6 Million - $2.05 Million	90,465 New	90,465 $1.6 Million
Q3 2019 Mar 30, 2023	SELL	$17.68 - $22.65 $178,868 - $229,150	-10,117 Reduced 10.06%	90,465 $1.6 Million
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $178,868 - $229,150	-10,117 Reduced 10.06%	90,465 $1.6 Million
Q2 2019 Jul 12, 2023	BUY	$18.93 - $24.75 $1.9 Million - $2.49 Million	100,582 New	100,582 $2.15 Million
Q2 2019 Mar 30, 2023	SELL	$18.93 - $24.75 $946 - $1,237	-50 Reduced 0.05%	100,582 $2.15 Million
Q2 2019 Aug 14, 2019	SELL	$18.93 - $24.75 $946 - $1,237	-50 Reduced 0.05%	100,582 $2.15 Million
Q1 2019 Jul 13, 2023	BUY	$19.6 - $24.76 $1.97 Million - $2.49 Million	100,632 New	100,632 $2.4 Million
Q1 2019 Mar 30, 2023	BUY	$19.6 - $24.76 $1.97 Million - $2.49 Million	100,632 New	100,632 $2.4 Million
Q1 2019 May 16, 2019	BUY	$19.6 - $24.76 $1.88 Million - $2.38 Million	96,050 Added 2096.25%	100,632 $2.4 Million
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $1.89 Million - $2.38 Million	-96,237 Reduced 95.46%	4,582 $102,000
Q4 2018 Jul 13, 2023	BUY	$13.65 - $21.8 $1.38 Million - $2.2 Million	100,819 New	100,819 $1.98 Million
Q4 2018 Feb 14, 2019	BUY	$13.65 - $21.8 $5,241 - $8,371	384 Added 0.38%	100,819 $1.98 Million
Q3 2018 Jul 13, 2023	BUY	$15.87 - $22.4 $1.59 Million - $2.25 Million	100,435 New	100,435 $1.78 Billion
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $1.23 Million - $1.73 Million	77,332 Added 334.73%	100,435 $1.78 Million
Q2 2018 Aug 15, 2018	BUY	$18.56 - $22.45 $23,422 - $28,331	1,262 Added 5.78%	23,103 $0
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $5,581 - $8,036	252 Added 1.17%	21,841 $0
Q4 2017 Feb 15, 2018	SELL	$24.23 - $30.93 $4,918 - $6,278	-203 Reduced 0.93%	21,589 $656,000
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $25,965 - $32,514	1,112 Added 5.38%	21,792 $528,000
Q2 2017 Aug 14, 2017	BUY	N/A	20,680	20,680 $509,000

Others Institutions Holding EXEL

# of Institutions

566

Shares Held

251M

Call Options Held

1.45M

Put Options Held

1.13M

Black Rock Inc. New York, NY

33.5M
Shares

$1.25 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.4M
Shares

$1.09 Billion
0.02% of portfolio
Farallon Capital Management LLC San Francisco, CA

23.4M
Shares

$871 Million
4.16% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.3M
Shares

$569 Million
0.8% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$424 Million
0.02% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $12B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account